Systems biology in hepatology: approaches and applications

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Nature reviews: Gastroenterology & hepatology

• Publication date

  2018-04-23

• Fields of study

  Biology, Medicine, Computer Science

• Identifiers
  DOI 10.1038/s41575-018-0007-8PMID 29686404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into Pathogenesis

  2017cited by this paper
• Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions

  2017cited by this paper
• A pathology atlas of the human cancer transcriptome

  2017cited by this paper
• Personal model‐assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD

  2017cited by this paper
• A subcellular map of the human proteome

  2017cited by this paper
• NAFLD and diabetes mellitus

  2017cited by this paper
• Metabolic zonation of the liver: The oxygen gradient revisited

  2017cited by this paper
• Network analyses identify liver‐specific targets for treating liver diseases

  2017cited by this paper
• Metabolomics and Metabolic Diseases: Where Do We Stand?

  2017cited by this paper
• Plasma Mannose Levels Are Associated with Incident Type 2 Diabetes and Cardiovascular Disease.

  2017cited by this paper
• TCSBN: a database of tissue and cancer specific biological networks

  2017cited by this paper
• Improving the economics of NASH/NAFLD treatment through the use of systems biology.

  2017cited by this paper
• Systems Biology of Metabolism: A Driver for Developing Personalized and Precision Medicine.

  2017cited by this paper
• Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota

  2016cited by this paper
• Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis

  2016cited by this paper
• Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis

  2016cited by this paper
• The gut microbiota and metabolic disease: current understanding and future perspectives

  2016cited by this paper
• Transcriptomics resources of human tissues and organs

  2016cited by this paper
• Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma

  2016cited by this paper
• Personalized Cardiovascular Disease Prediction and Treatment—A Review of Existing Strategies and Novel Systems Medicine Tools

  2016cited by this paper
• Confounding Effects of Metformin on the Human Gut Microbiome in Type 2 Diabetes.

  2016cited by this paper
• Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level.

  2016cited by this paper
• Imbalanced insulin action in chronic over nutrition: Clinical harm, molecular mechanisms, and a way forward.

  2016cited by this paper
• Editorial: The Impact of Systems Medicine on Human Health and Disease

  2016cited by this paper
• Investigating the Combinatory Effects of Biological Networks on Gene Co-expression

  2016cited by this paper
• Human gut microbes impact host serum metabolome and insulin sensitivity

  2016cited by this paper
• Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease

  2016cited by this paper
• Integrated Network Analysis Reveals an Association between Plasma Mannose Levels and Insulin Resistance.

  2016cited by this paper
• Glycosaminoglycan Profiling in Patients' Plasma and Urine Predicts the Occurrence of Metastatic Clear Cell Renal Cell Carcinoma.

  2016cited by this paper
• Liver: Phenotypic and genetic variance: a systems approach to the liver

  2016cited by this paper
• Kinetics of plasma triglycerides in abdominal obesity

  2016cited by this paper
• Systems proteomics of liver mitochondria function

  2016cited by this paper
• When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis

  2016cited by this paper
• New paradigms for metabolic modeling of human cells.

  2015cited by this paper
• Kinetic Studies to Elucidate Impaired Metabolism of Triglyceride-rich Lipoproteins in Humans

  2015cited by this paper
• Progress and prospects of long noncoding RNAs in lipid homeostasis

  2015cited by this paper
• Using Genome-scale Models to Predict Biological Capabilities.

  2015cited by this paper
• Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling

  2015cited by this paper
• Modeling cancer metabolism on a genome scale

  2015cited by this paper
• The promise of metabolic phenotyping in gastroenterology and hepatology

  2015cited by this paper
• New insights into the pathophysiology of dyslipidemia in type 2 diabetes.

  2015cited by this paper
• Stratification of Hepatocellular Carcinoma Patients Based on Acetate Utilization.

  2015cited by this paper
• Tissue-based map of the human proteome

  2015cited by this paper
• Complementing tissue characterization by integrating transcriptome profiling from the Human Protein Atlas and from the FANTOM5 consortium

  2015cited by this paper
• Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine.

  2015cited by this paper
• Logical transformation of genome-scale metabolic models for gene level applications and analysis

  2015cited by this paper
• Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome.

  2015cited by this paper
• Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.

  2015cited by this paper
• Cancer Metabolism: A Modeling Perspective

  2015cited by this paper
• Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease

  2014cited by this paper
• Constraint-based models predict metabolic and associated cellular functions

  2014cited by this paper
• Phenotypic Robustness and the Assortativity Signature of Human Transcription Factor Networks

  2014cited by this paper
• STRING v10: protein–protein interaction networks, integrated over the tree of life

  2014cited by this paper
• Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease.

  2014cited by this paper
• Protein-protein interaction networks (PPI) and complex diseases

  2014cited by this paper
• The BioGRID interaction database: 2015 update

  2014cited by this paper
• A draft map of the human proteome

  2014cited by this paper
• The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes

  2014cited by this paper
• Mass-spectrometry-based draft of the human proteome

  2014cited by this paper
• The human liver‐specific proteome defined by transcriptomics and antibody‐based profiling

  2014cited by this paper
• Elucidating the interactions between the human gut microbiota and its host through metabolic modeling

  2014cited by this paper
• Hepatocellular carcinoma: Genome-scale metabolic models for hepatocellular carcinoma

  2014cited by this paper
• Non-alcoholic fatty liver disease: a practical approach to treatment

  2014cited by this paper
• Liver zonation: Novel aspects of its regulation and its impact on homeostasis.

  2014cited by this paper
• Robustness and Evolvability of the Human Signaling Network

  2014cited by this paper
• NAFLD: Metabolic make-up of NASH: from fat and sugar to amino acids

  2014cited by this paper
• Metabolomics study of hepatocellular carcinoma: discovery and validation of serum potential biomarkers by using capillary electrophoresis-mass spectrometry.

  2014cited by this paper
• Identification of anticancer drugs for hepatocellular carcinoma through personalized genome‐scale metabolic modeling

  2014cited by this paper
• A Systems Approach to Predict Oncometabolites via Context-Specific Genome-Scale Metabolic Networks

  2014cited by this paper
• Phenotype-based cell-specific metabolic modeling reveals metabolic liabilities of cancer

  2014cited by this paper
• A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration

  2014cited by this paper
• Construction and Validation of a Regulatory Network for Pluripotency and Self-Renewal of Mouse Embryonic Stem Cells

  2014cited by this paper
• Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

  2013cited by this paper
• A diabetes-predictive amino acid score and future cardiovascular disease.

  2013cited by this paper
• Fast Reconstruction of Compact Context-Specific Metabolic Network Models

  2013cited by this paper
• Model-based identification of drug targets that revert disrupted metabolism and its application to ageing

  2013cited by this paper
• Gut metagenome in European women with normal, impaired and diabetic glucose control

  2013cited by this paper
• Dietary intervention impact on gut microbial gene richness

  2013cited by this paper
• Genome‐scale modeling of human metabolism – a systems biology approach

  2013cited by this paper
• Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

  2013cited by this paper
• A community-driven global reconstruction of human metabolism

  2013cited by this paper
• Metabolomic signatures of aggressive prostate cancer

  2013cited by this paper
• Metabolically re-modeling the drug pipeline.

  2013cited by this paper
• Integration of clinical data with a genome-scale metabolic model of the human adipocyte

  2013cited by this paper
• The Genotype-Tissue Expression (GTEx) project

  2013cited by this paper
• Understanding the interactions between bacteria in the human gut through metabolic modeling

  2013cited by this paper
• A whole-cell computational model predicts phenotype from genotype.

  2012cited by this paper
• Reconstruction of Genome-Scale Active Metabolic Networks for 69 Human Cell Types and 16 Cancer Types Using INIT

  2012cited by this paper
• Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE

  2012cited by this paper
• STRING v9.1: protein-protein interaction networks, with increased coverage and integration

  2012cited by this paper
• Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

  2012cited by this paper
• Architecture of the human regulatory network derived from ENCODE data

  2012cited by this paper
• Symptomatic atherosclerosis is associated with an altered gut metagenome

  2012cited by this paper
• Systems medicine and metabolic modelling

  2012cited by this paper
• Mining the Unknown: A Systems Approach to Metabolite Identification Combining Genetic and Metabolic Information

  2012cited by this paper
• Circuitry and dynamics of human transcription factor regulatory networks.

  2012cited by this paper
• Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans

  2012cited by this paper
• Personalized Cancer Medicine: Molecular Diagnostics, Predictive biomarkers, and Drug Resistance

  2012cited by this paper
• Metabolic Signatures of Insulin Resistance in 7,098 Young Adults

  2012cited by this paper
• Alanine and aspartate aminotransferase and glutamine-cycling pathway: their roles in pathogenesis of metabolic syndrome.

  2012cited by this paper

• Effects of chitosan supplementation versus placebo on liver fat and metabolic parameters in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.

  2026cites this paper
• Artemisinin toxicity in HepG2 liver carcinoma cells is linked to protein network in host and molecular interactions with cellular drug targets.

  2025cites this paper
• Longitudinal big biological data in the AI era

  2025cites this paper
• Degradable hybrid hydrogel scaffolds consisting of protein and polysaccharide compounds based on a PVA polymer modified with urea oligomers for liver cells.

  2025cites this paper
• Incorporation of alpha lipoic acid into polymer-lipid nanoparticles enhances its antifibrotic activity in an in vitro model using human hepatic stellate cells

  2025cites this paper
• A Comprehensive Review of Harnessing Bioinformatics in Biochemistry: A New Era of Data-Driven Discoveries and Applications

  2025cites this paper
• Multi-omics characterization of improved cognitive functions in Parkinson’s disease patients after the combined metabolic activator treatment: a randomized, double-blinded, placebo-controlled phase II trial

  2025cites this paper
• Mesenchymal stromal/stem cell spheroid-derived extracellular vesicles advance the therapeutic efficacy of 3D-printed vascularized artificial liver lobules in liver failure treatment

  2025cites this paper
• Integrative proteo-transcriptomic characterization of advanced fibrosis in chronic liver disease across etiologies

  2025cites this paper
• Evaluation of the Pogostone in an Acetaminophen-induced Liver Injury Rat Model

  2025cites this paper
• Synthesis and biological assessment of BUB1B inhibitors for the treatment of clear cell renal cell carcinoma.

  2025cites this paper
• Targeting PKLR in liver diseases.

  2025cites this paper
• Precision Medicine in Hepatobiliary Diseases: A Clinical Review.

  2024cites this paper
• Multi-tissue network analysis reveals the effect of JNK inhibition on dietary sucrose-induced metabolic dysfunction in rats

  2024cites this paper
• System-level integrative omics analysis to identify the virus-host immunometabolic footprint during infection.

  2024cites this paper
• Unveiling the Molecular Mechanisms of Glioblastoma through an Integrated Network-Based Approach

  2024cites this paper
• Genome-scale models in human metabologenomics

  2024cites this paper
• Discovery of a Therapeutic Agent for Glioblastoma Using a Systems Biology-Based Drug Repositioning Approach

  2024cites this paper
• Polymer-Based Wound Dressings Loaded with Essential Oil for the Treatment of Wounds: A Review

  2024cites this paper
• Design and evaluation of novel inhibitors for the treatment of clear cell renal cell carcinoma.

  2024cites this paper
• Systems Modeling Reveals Shared Metabolic Dysregulation and Potential Treatments in ME/CFS and Long COVID

  2024cites this paper
• Soy Peptide Supplementation Mitigates Undernutrition through Reprogramming Hepatic Metabolism in a Novel Undernourished Non‐Human Primate Model

  2024cites this paper
• System biology approaches for drug repurposing.

  2024cites this paper
• Prioritization of genes for translation: a computational approach

  2024cites this paper
• Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

  2023cites this paper
• Electroacupuncture treatment ameliorates metabolic disorders in obese ZDF rats by regulating liver energy metabolism and gut microbiota

  2023cites this paper
• High-confidence structural identification of metabolites relying on tandem mass spectrometry through isomeric identification: A tutorial

  2023cites this paper
• Deciphering the toxicity-effect relationship and action patterns of traditional Chinese medicines from a smart data perspective: a comprehensive review

  2023cites this paper
• Iron oxide nanoparticles trigger endoplasmic reticulum damage in steatotic hepatic cells

  2023cites this paper
• Ambient NO2 Exposure Affects Hepatic Glycolipid Metabolism in Mice With A Sex-dependent Property

  2022cites this paper
• [The promise of omics in the precision medicine era].

  2022cites this paper
• System and network biology-based computational approaches for drug repositioning

  2022cites this paper
• A Quantitative Systems Pharmacology Platform Reveals NAFLD Pathophysiological States and Targeting Strategies

  2022cites this paper
• Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment

  2022cites this paper
• System‐level metabolic modeling facilitates unveiling metabolic signature in exceptional longevity

  2022cites this paper
• Gene by Environment Interactions reveal new regulatory aspects of signaling network plasticity

  2022cites this paper
• Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach

  2022cites this paper
• Developing tissue engineering strategies for liver regeneration

  2022cites this paper
• Ficolin-2 Plasma Level Assesses Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

  2022cites this paper
• Repeated toxic injuries of murine liver are tolerated through microsteatosis and mild inflammation

  2022cites this paper
• Drug discovery is an eternal challenge for the biomedical sciences

  2022cites this paper
• Understanding Nanomaterial–Liver Interactions to Facilitate the Development of Safer Nanoapplications

  2022cites this paper
• Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases.

  2022cites this paper
• Oat β-Glucan Ameliorates Diabetes in High Fat Diet and Streptozotocin-induced Mice by Regulating Metabolites.

  2022cites this paper
• Metabolic Modeling of Hermetia illucens Larvae Resource Allocation for High-Value Fatty Acid Production

  2022cites this paper
• Constructing biomimetic liver models through biomaterials and vasculature engineering

  2022cites this paper
• A network-based approach reveals the dysregulated transcriptional regulation in non-alcohol fatty liver disease

  2021cites this paper
• Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease.

  2021cites this paper
• Multi-omics approaches for revealing the complexity of cardiovascular disease

  2021cites this paper
• The Role of Gut Microbiota in Duodenal-Jejunal Bypass Surgery-Induced Improvement of Hepatic Steatosis in HFD-Fed Rats

  2021cites this paper
• Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors

  2021cites this paper
• Scrutinizing the Disease Based on Omics

  2021cites this paper
• Combined Metabolic Activators Reduces Liver Fat in Nonalcoholic Fatty Liver Disease Patients

  2021influential citation
• Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis

  2021cites this paper
• Systems Analysis Reveals Ageing-Related Perturbations in Retinoids and Sex Hormones in Alzheimer’s and Parkinson’s Diseases

  2021cites this paper
• Combined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19

  2021cites this paper
• Stratification of patients with clear cell renal cell carcinoma to facilitate drug repositioning

  2021cites this paper
• Combined Metabolic Activators Improves Cognitive Functions in Alzheimer's Disease

  2021cites this paper
• Integrative Gene Expression and Metabolic Analysis Tool IgemRNA

  2021cites this paper
• Integrative analysis identified common and unique molecular signatures in hepatobiliary cancers

  2021cites this paper
• Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients

  2021cites this paper
• A network-based approach reveals the dysregulated transcriptional regulation in non-alcoholic fatty liver disease

  2021cites this paper
• Revealing the Molecular Mechanisms of Alzheimer’s Disease Based on Network Analysis

  2021cites this paper
• Integrative transcriptomic analysis of tissue-specific metabolic crosstalk after myocardial infarction

  2021cites this paper
• Acute kidney injury leading to CKD is associated with a persistence of metabolic dysfunction and hypertriglyceridemia

  2020cites this paper
• Exercise-induced molecular mechanisms in untrained and life-long highly trained individuals

  2020cites this paper
• Revealing tissue-specific metabolic crosstalk after a myocardial infarction

  2020cites this paper
• Clinical and Molecular Prediction of Hepatocellular Carcinoma Risk

  2020cites this paper
• Endogenous Metabolic Modulators: Emerging Therapeutic Potential of Amino Acids

  2020cites this paper
• Systems Biology: A Multi-Omics Integration Approach to Metabolism and the Microbiome

  2020cites this paper
• Combined metabolic cofactor supplementation accelerates recovery in mild-to-moderate COVID-19

  2020cites this paper
• Disease, Drugs and Dysbiosis: Understanding Microbial Signatures in Metabolic Disease and Medical Interventions

  2020cites this paper
• Reinventing Molecular Imaging with Total-Body PET, Part II

  2020cites this paper
• Dendrobium officinale polysaccharide ameliorates the liver metabolism disorders of type II diabetic rats.

  2020cites this paper
• Systems Biology Approaches to Understanding the Human Immune System

  2020cites this paper
• Systems Biology Approaches to Understand the Host–Microbiome Interactions in Neurodegenerative Diseases

  2020cites this paper
• Skeletal Muscle Transcriptomic Comparison between Long-Term Trained and Untrained Men and Women.

  2020cites this paper
• A systems biology approach for studying neurodegenerative diseases.

  2020cites this paper
• The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non‐alcoholic fatty liver disease

  2020cites this paper
• Improvement in the Current Therapies for Hepatocellular Carcinoma Using a Systems Medicine Approach

  2020cites this paper
• Identifying Molecular Biomarkers for Diseases With Machine Learning Based on Integrative Omics

  2020cites this paper
• Genome-Scale Metabolic Modeling of Glioblastoma Reveals Promising Targets for Drug Development

  2020cites this paper
• Addressing the heterogeneity in liver diseases using biological networks

  2020cites this paper
• Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice

  2019cites this paper
• Classification of clear cell renal cell carcinoma based on PKM alternative splicing

  2019cites this paper
• Coordinated changes of gut microbiome and lipidome differentiates nonalcoholic steatohepatitis (NASH) from isolated steatosis

  2019cites this paper
• Systems biology based drug repositioning for development of cancer therapy.

  2019cites this paper
• Metabolomics and proteomics as tools to advance the understanding of exercise responses: The emerging role of gut microbiota in athlete health and performance

  2019cites this paper
• Elucidating the Reprograming of Colorectal Cancer Metabolism Using Genome-Scale Metabolic Modeling

  2019cites this paper
• The Potential Use of Metabolic Cofactors in Treatment of NAFLD

  2019cites this paper
• Identifying potential drug targets in hepatocellular carcinoma based on network analysis and one-class support vector machine

  2019cites this paper
• Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease

  2019cites this paper
• RMetD2: a tool for integration of relative transcriptomics data into Genome-scale metabolic models

  2019cites this paper
• Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer

  2019cites this paper
• Lipopolysaccharide protects against acetaminophen-induced hepatotoxicity by reducing oxidative stress via the TNF-α/TNFR1 pathway.

  2019cites this paper
• Reconstruction of context-specific genome-scale metabolic models using multiomics data to study metabolic rewiring

  2019cites this paper
• Current Models of Fatty Liver Disease; New Insights, Therapeutic Targets and Interventions.

  2019cites this paper
• Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning

  2019cites this paper
• The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)

  2019cites this paper
• Pyruvate kinase L/R is a regulator of lipid metabolism and mitochondrial function.

  2019cites this paper